Vicept Therapeutics
Vicept Therapeutics is a biopharmaceutical company developing topically applied-therapy for the treatment of dermatologic disorders.
Business Model:
Revenue: $11.2M
Employees: 11-50
Rankings
Industries / Tags:
Detailed Vicept Therapeutics Information
Vicept Therapeutics was acquired by
Allergan.
The acquisition happend on 2011-07-19.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 101 Lindenwood Dr
City: Malvern
State: PA
Zip: 19355
Country: US
Financial Info
Stage:
series a
Raised Last:
$16M
Raised Total:$16M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Vicept (Vicept Therapeutics, Inc.), based in Malvern, Pennsylvania, is a privately held specialty biopharmaceutical company founded in August, 2009 with a mission to develop the first effective topically applied-therapy directed toward the erythema (skin redness) of rosacea and other dermatologic disorders characterized by redness and or &s;flushing&s; of the skin.
Contact Phone:
+14843242930
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 6/2010 | Series A | 4 | $16M |
F-Prime Capital Sofinnova Investments UCLA Ventures Vivo Capital F-Prime Capital Sofinnova Investments UCLA Ventures Vivo Capital |
1/2009 | Venture Round | 2 | - |
Eight Roads Ventures Sofinnova Investments Eight Roads Ventures Sofinnova Investments |
1/2009 | Venture Round | 2 | - |
Eight Roads Ventures Sofinnova Investments Eight Roads Ventures Sofinnova Investments |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
